Women’s Health Market Insights:
Women’s Health Market is projected to be worth USD 56.12 Billion by 2030, registering a CAGR of 4.7% CAGR during the forecast period (2022-2030), the market was valued at USD 37.12 Billion in 2021. The contraceptives market sector maintained the largest market share, accounting for more than 32.8% of overall revenue in 2021, due to rising family planning awareness and quick technological improvements in contraception. Due to a rise in life expectancy that is increasing the menopausal population globally, the age group 50 and above is anticipated to experience the fastest growth rate during the forecast period. In 2021, North America held the largest market share, accounting for more than 40.10% of worldwide sales.
Women’s Health Market Dynamics:
Women’s health is defined as a state of physical health, which goes beyond simple health or the absence of sickness or infirmity. The rise in the number of elderly women and the release of new drugs for women’s health, such as Relugoliz and Orilissa, are both factors contributing to market expansion. Additionally, the market is anticipated to be driven by positive government initiatives to enhance women’s health and increase awareness.
Driver:
The market is expanding primarily as a result of factors such as the rising prevalence of chronic illnesses in women, governmental programs to slow population growth, and rising demand for contraceptives to avoid unwanted pregnancies. Additionally, a significant reason for the market’s growth is the increasing emphasis that leading players are placing on R&D for the creation of cutting-edge products.
Restraint:
Women are more likely than males to have life-threatening illnesses, some obstacles are preventing the expansion of the women’s healthcare sector. The negative effects that various medications side effects have on women’s health is one such element. As an illustration, using birth control pills can have several adverse effects, including spotting or bleeding in between periods, sore breasts, nausea, migraines, etc. Additionally, adverse effects from osteoporosis medications include headaches and joint pain are possible.
Opportunities
Emerging markets such as China, India, Japan, and others are anticipated to create lucrative growth opportunities for the market during the forecast period. Further, a government initiative to generate awareness among young individuals, and advanced treatment
COVID-19 Analysis of Women’s Health Market:
Unprecedented lockdowns brought on by the COVID-19 epidemic have disrupted daily life and altered consumer behavior in almost every sector. Retail establishments have closed while COVID-19 reaction efforts intensify. Due to the statewide suspension of transportation and manufacture in significant raw material-producing nations like China and India, the industry began to experience a supply deficit. Additionally, the availability of additional raw materials has been restricted as a result of supply chain disruptions in the U.S., which is impacting manufacturing and, consequently, the supply chain of products. Hence, COVID-19 harmed the women’s health market
Women’s Health Market Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 56.12 Billion |
| CAGR (2022-2030) | 4.7% |
| By Application | Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS) |
| By Age | 50 Years & above (Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause) and Others |
| By geography | North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) The Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | AbbVie, Inc., Bayer AG; Merck & Co., Inc., Pfizer, Inc, Teva Pharmaceutical Industries Ltd., Agile Therapeutics; Amgen, Inc, Apothecus Pharmaceutical Corp., Blairex Laboratories, Inc., Ferring B.V. |
Women’s Health Market Segment Analysis:
By Application
The contraceptives market sector maintained the largest market share, accounting for more than 32.8% of overall revenue in 2021, due to rising family planning awareness and quick technological improvements in contraception. The demand for contraceptives is expected to increase as a result of promising government legislation in nations like the U.S. and increased public awareness of the many contraceptive options. For instance, all female-controlled contraceptive methods must be paid by insurance without any patient out-of-pocket expenses under U.S. federal law.
By Age
The global market has been further divided by age category into 50 years and older and others. Due to a rise in life expectancy that is increasing the menopausal population globally, the age group 50 and above is anticipated to experience the fastest growth rate of more than 6.00% over the projected period. Additionally, disorders like postmenopausal osteoporosis are on the rise along with the aging population. In the upcoming years, all of these elements are anticipated to fuel this segment’s expansion.
By Region
In 2021, North America held the largest market share, accounting for more than 40.10% of worldwide sales. Throughout the forecast period, the region will continue to grow at a constant CAGR, preserving its market position. Early product approval and commercialization, good reimbursement practices, helpful government laws, and widespread recognition of the value of maintaining good health were all cited as contributing factors to this increase. For instance, the Canadian government contributed USD 50.47 million to family planning during the 2020–2021 fiscal year, which enabled 2.5 million women and couples to get contraceptive products and services.
Women’s Health Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), Product & Service innovation, various business strategies, and Product & Service launches have accelerated the growth of the Women’s Health market. Key players in the market include-
- AbbVie, Inc.
- Bayer AG
- Merck & Co., Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Agile Therapeutics
- Amgen, Inc.
- Apothecus Pharmaceutical Corp.
- Blairex Laboratories, Inc.
- Ferring B.V.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Application Picture of Women’s Health
- Global Women’s Health Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Women’s Health Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Therapeutic
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Application Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Women’s Health Market demand
- Post-Covid Impact on Women’s Health Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Women’s Health Market Segmentation, Revenue (USD Billion), (2022-2030)
- By Application
- Postmenopausal Osteoporosis
- Hormonal Infertility
- Endometriosis & Uterine Fibroids
- Contraceptives
- Menopause
- Polycystic Ovary Syndrome (PCOS)
- By Age
- 50 Years & above
- Postmenopausal Osteoporosis
- Endometriosis & Uterine Fibroids
- Menopause
- Others
- 50 Years & above
- By Application
- By Global Women’s Health Market Overview, By Region
- North America Women’s Health Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Application
- By Age
- Canada
- Mexico
- US
- Europe Women’s Health Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Women’s Health Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Women’s Health Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Women’s Health Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Women’s Health Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Women’s Health Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- AbbVie, Inc.
- Business Overview
- Business Financials (USD Billion)
- Application Category, Source, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- AbbVie, Inc.
- Bayer AG
- Merck & Co., Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Agile Therapeutics
- Amgen, Inc.
- Apothecus Pharmaceutical Corp.
- Blairex Laboratories, Inc.
- Ferring B.V.
- AbbVie, Inc.
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.